Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours



Rating:

Share or cite this content

Citations should be made in the following way:
G. E. Carpagnano, G. Scioscia, D. Lacedonia, A. Spanevello, D. Martinelli, V. Saliani, C. Ruggieri, M.P. Foschino-Barbaro (Foggia, Italy). Exhaled breath temperature in NSCLC: Could be a new non invasive marker?. Eur Respir J 2014; 44: Suppl. 58, 1928

Member's Comments

No comment yet.

Related content which might interest you: The research on early detection of lung cancer with exhaled volatile organic compounds Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Methilation status in EBUS-NA samples of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Symptom-to-treatment intervals in lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Early detection of lung cancer in exhaled breath condensate using miRNA markers Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 The value of miR221 and miR222 as a biomarker in non small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Lung cancer in women: Is it different? Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Metabolomic analysis of serum samples from patients with lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Metabolic signatures associated with lung cancer using serum samples. Influence of hemolysis Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Treatment of pulmonary carcinoid: Are there new options? Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Comorbitities, responses and survival in pts with NSCLC Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 LATE-BREAKING ABSTRACT: Are small specimens" big enough" as therapeutic indicators in non-small cell lung cancer? Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Bronchiolo-alveolar carcinoma- sometimes a difficult diagnosis Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Detection of early stage lung cancer by electronic nose Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Second primary lung cancer in squamous NSCLC patients: The Nancy Biobank's database Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Functional impairment of NK cells in non-small-cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Stereotactic ablative radiotherapy (SABR) in non-surgical non small cell lung cancer: Effects on respiratory function Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment? Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015 Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013